MO Stock Analysis — Altria Group
Sector: Consumer Staples
AI Verdict
Altria trades at a low 12.4x forward earnings despite a defensible tobacco moat and 25.9% expected EPS growth—cheap for the growth you're getting, but the story depends on that growth actually showing up.
Competitive Moat
Altria dominates the U.S. tobacco market with Marlboro, a brand that commands exceptional pricing power and customer loyalty. Regulatory barriers and high taxes make it nearly impossible for new entrants to challenge its entrenched position.
Summary
Altria is notable right now for trading at just 12.4x next year's earnings while analysts expect a 25.9% EPS jump.
Where It Stands
The stock is up 26.71% over the past year, RSI sits at a neutral 61.9, and its 12.4x forward P/E is a steep discount to the consumer staples median of 20x.
Key Metrics
- RSI: 61.9 — Near Overbought
- Trailing P/E: 15.6x
- Forward P/E: 12.4x
- PEG Ratio: 0.62
- Earnings Growth: +0.3%
- Revenue Growth: -0.0%
- Market Cap: $124.7B
- Dividend Yield: 0.06%
- 1-Year Return: 26.71%
- 52-Week High: $75.28
- 52-Week Low: $54.70
Analyst Consensus
12 Buy · 8 Hold · 3 Sell (23 analysts)
Bull Case
You're paying only 12.4x forward earnings for a business expected to grow EPS by 25.9% next year, which is cheap for the growth on offer.
Bear Case
If the forward P/E reverts to the sector median of 20x, upside is possible, but if it slips to the trailing P/E of 15.6x, that's a 26% multiple compression risk from here.
Catalyst to Watch
Watch for FDA regulatory decisions or new product launches in reduced-risk nicotine, as either could materially shift growth expectations.